Synopsis
0
USDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
FDA Orange Book
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
12
PharmaCompass offers a list of Tiapride Hydrochloride API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Tiapride Hydrochloride manufacturer or Tiapride Hydrochloride supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Tiapride Hydrochloride manufacturer or Tiapride Hydrochloride supplier.
PharmaCompass also assists you with knowing the Tiapride Hydrochloride API Price utilized in the formulation of products. Tiapride Hydrochloride API Price is not always fixed or binding as the Tiapride Hydrochloride Price is obtained through a variety of data sources. The Tiapride Hydrochloride Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Tiapridex manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Tiapridex, including repackagers and relabelers. The FDA regulates Tiapridex manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Tiapridex API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Tiapridex manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Tiapridex supplier is an individual or a company that provides Tiapridex active pharmaceutical ingredient (API) or Tiapridex finished formulations upon request. The Tiapridex suppliers may include Tiapridex API manufacturers, exporters, distributors and traders.
click here to find a list of Tiapridex suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Tiapridex Drug Master File in Japan (Tiapridex JDMF) empowers Tiapridex API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Tiapridex JDMF during the approval evaluation for pharmaceutical products. At the time of Tiapridex JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Tiapridex suppliers with JDMF on PharmaCompass.
A Tiapridex CEP of the European Pharmacopoeia monograph is often referred to as a Tiapridex Certificate of Suitability (COS). The purpose of a Tiapridex CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Tiapridex EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Tiapridex to their clients by showing that a Tiapridex CEP has been issued for it. The manufacturer submits a Tiapridex CEP (COS) as part of the market authorization procedure, and it takes on the role of a Tiapridex CEP holder for the record. Additionally, the data presented in the Tiapridex CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Tiapridex DMF.
A Tiapridex CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Tiapridex CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Tiapridex suppliers with CEP (COS) on PharmaCompass.
Tiapridex Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Tiapridex GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Tiapridex GMP manufacturer or Tiapridex GMP API supplier for your needs.
A Tiapridex CoA (Certificate of Analysis) is a formal document that attests to Tiapridex's compliance with Tiapridex specifications and serves as a tool for batch-level quality control.
Tiapridex CoA mostly includes findings from lab analyses of a specific batch. For each Tiapridex CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Tiapridex may be tested according to a variety of international standards, such as European Pharmacopoeia (Tiapridex EP), Tiapridex JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Tiapridex USP).
